Literature DB >> 17483811

Ablative techniques for the management of kidney cancer.

Jason Hafron1, Jihad H Kaouk.   

Abstract

For lesions smaller than 4 cm, nephron-sparing surgery has been shown to be oncologically equivalent to radical nephrectomy, albeit with the advantage of preservation of overall renal function. As such, partial nephrectomy became the first-line treatment option for localized, small renal masses. Minimally invasive options associated with limited morbidity--such as probe-ablative procedures--are, however, being investigated in selected patients for whom invasive, nephron-sparing surgery (whether laparoscopic or open) is undesirable. The main probe-ablative techniques being investigated as alternatives to partial nephrectomy are cryoablation, radiofrequency ablation, and high-intensity focused ultrasound. Advances in imaging, ablative system technologies, and early evidence that in situ tumor ablation can yield comparable results to those achieved with tumor resection in selected cases, have sparked significant interest in these minimally invasive techniques.

Entities:  

Mesh:

Year:  2007        PMID: 17483811     DOI: 10.1038/ncpuro0802

Source DB:  PubMed          Journal:  Nat Clin Pract Urol        ISSN: 1743-4270


  6 in total

1.  Integrated optical coherence tomography and optical coherence microscopy imaging of ex vivo human renal tissues.

Authors:  Hsiang-Chieh Lee; Chao Zhou; David W Cohen; Amy E Mondelblatt; Yihong Wang; Aaron D Aguirre; Dejun Shen; Yuri Sheikine; James G Fujimoto; James L Connolly
Journal:  J Urol       Date:  2011-12-16       Impact factor: 7.450

2.  Radiofrequency ablation versus nephron-sparing surgery for small unilateral renal cell carcinoma: cost-effectiveness analysis.

Authors:  Pari V Pandharipande; Debra A Gervais; Peter R Mueller; Chin Hur; G Scott Gazelle
Journal:  Radiology       Date:  2008-05-05       Impact factor: 11.105

3.  Changing concepts in the surgery of renal cell carcinoma.

Authors:  Axel S Merseburger; Markus A Kuczyk
Journal:  World J Urol       Date:  2008-02-12       Impact factor: 4.226

4.  Assessment of the radiofrequency ablation dynamics of esophageal tissue with optical coherence tomography.

Authors:  Hsiang-Chieh Lee; Osman O Ahsen; Jonathan J Liu; Tsung-Han Tsai; Qin Huang; Hiroshi Mashimo; James G Fujimoto
Journal:  J Biomed Opt       Date:  2017-07-01       Impact factor: 3.170

5.  Irreversible Electroporation for the Ablation of Renal Cell Carcinoma: A Prospective, Human, In Vivo Study Protocol (IDEAL Phase 2b).

Authors:  Mara Buijs; Krijn P van Lienden; Peter Gk Wagstaff; Matthijs Jv Scheltema; Daniel M de Bruin; Patricia J Zondervan; Otto M van Delden; Ton G van Leeuwen; Jean Jmch de la Rosette; M Pilar Laguna
Journal:  JMIR Res Protoc       Date:  2017-02-16

6.  Validation of a low-cost, carbon dioxide-based cryoablation system for percutaneous tumor ablation.

Authors:  Bailey Surtees; Sean Young; Yixin Hu; Guannan Wang; Evelyn McChesney; Grace Kuroki; Pascal Acree; Serena Thomas; Tara Blair; Shivam Rastogi; Dara L Kraitchman; Clifford Weiss; Saraswati Sukumar; Susan C Harvey; Nicholas J Durr
Journal:  PLoS One       Date:  2019-07-03       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.